Evidence map›Paper›PMID 29253101›Full record

ArticleBrain : a journal of neurology2018

A novel human pain insensitivity disorder caused by a point mutation in ZFHX2.

Abdella M Habib, Ayako Matsuyama, Andrei L Okorokov, Sonia Santana-Varela, Jose T Bras, Anna Maria Aloisi, Edward C Emery, Yury D Bogdanov, Maryne Follenfant, Sam J Gossage and 23 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. A conservedbioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Homozygosity for a RareInternational journal of molecular sciences · 2024
    Article
  8. Pathology of pain and its implications for therapeutic interventions.Signal transduction and targeted therapy · 2024
    Review
  9. Article
  10. Article
  11. Gpr83 Tunes Nociceptor Function, Controlling Pain.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Article
  12. Genetic pain loss disorders.Nature reviews. Disease primers · 2022
    Review
  13. Article
  14. Article
  15. The development of somatosensory neurons: Insights into pain and itch.Current topics in developmental biology · 2021
    Review
  16. Review
  17. Sensory neuron-derived NaScience advances · 2020
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 5 institutions in 5 countries.

Abdella M HabibMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Ayako MatsuyamaMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Andrei L OkorokovMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Sonia Santana-VarelaMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Jose T BrasDepartment of Molecular Neuroscience, Institute of Neurology, University College London, London, WC1N 3BG, UK.
Anna Maria AloisiDepartment of Medicine, Surgery and Neuroscience, University of Siena, via Aldo Moro, 2, 53100 Siena, Italy.
Edward C EmeryMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Yury D BogdanovMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Maryne FollenfantMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Sam J GossageMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Mathilde GrasMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Jack HumphreyMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Anna KolesnikovMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Kim Le CannMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Shengnan LiMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Michael S MinettMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Vanessa PereiraMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Clara PonsollesMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Shafaq SikandarMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Jesus M TorresMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Kenji YamaokaMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Jing ZhaoMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
Yuriko KomineNational Institute for Basic Biology, Okazaki, 444-8585, Japan.
Tetsuo YamamoriNational Institute for Basic Biology, Okazaki, 444-8585, Japan.
Nikolas ManiatisDepartment of Genetics, Evolution and Environment, University College London, London, WC1E 6BT, UK.
Konstantin I PanovMedical Biology Centre, School of Biological Sciences, Queen's University Belfast, Belfast, BT9 7BL, UK.
Henry HouldenDepartment of Molecular Neuroscience, Institute of Neurology, University College London, London, WC1N 3BG, UK.
Juan D RamirezNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.
David L H BennettNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.
Letizia MarsiliDepartment of Physical Sciences, Earth and Environment, University of Siena, 53100 Siena, Italy.
Valeria BachioccoDepartment of Medicine, Surgery and Neuroscience, University of Siena, via Aldo Moro, 2, 53100 Siena, Italy.
John N WoodMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
James J CoxMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK.
University College London · GBUniversity of Siena · ITNational Institute for Basic Biology · JPUniversity of Oxford · GBQueen's University Belfast · GB

Funding

Arthritis Research UK 20200Medical Research Council G1100340Wellcome TrustWellcome Trust 095698Z/11/ZWellcome Trust 101054/Z/13/ZWellcome Trust 200183/Z/15/ZWellcome Trust 202747/Z/16/Z
6 · The paper itself

Abstract

Chronic pain is a major global public health issue causing a severe impact on both the quality of life for sufferers and the wider economy. Despite the significant clinical burden, little progress has been made in terms of therapeutic development. A unique approach to identifying new human-validated analgesic drug targets is to study rare families with inherited pain insensitivity. Here we have analysed an otherwise normal family where six affected individuals display a pain insensitive phenotype that is characterized by hyposensitivity to noxious heat and painless bone fractures. This autosomal dominant disorder is found in three generations and is not associated with a peripheral neuropathy. A novel point mutation in ZFHX2, encoding a putative transcription factor expressed in small diameter sensory neurons, was identified by whole exome sequencing that segregates with the pain insensitivity. The mutation is predicted to change an evolutionarily highly conserved arginine residue 1913 to a lysine within a homeodomain. Bacterial artificial chromosome (BAC) transgenic mice bearing the orthologous murine p.R1907K mutation, as well as Zfhx2 null mutant mice, have significant deficits in pain sensitivity. Gene expression analyses in dorsal root ganglia from mutant and wild-type mice show altered expression of genes implicated in peripheral pain mechanisms. The ZFHX2 variant and downstream regulated genes associated with a human pain-insensitive phenotype are therefore potential novel targets for the development of new analgesic drugs.awx326media15680039660001.

Indexed as

Action PotentialsAdolescentAdultAgedAnimalsCalciumCapsaicinDisease Models, AnimalFemaleGanglia, SpinalGene Expression RegulationHumansHyperalgesiaMaleMiceMice, Inbred C57BLCalciumCapsaicinZinc Finger E-box Binding Homeobox 2dorsal root gangliaMendelianpain insensitivitytranscription factor

Identifiers

PMID29253101
PMCPMC5837393
OpenAlexW2772249211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.